Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Bimodal Solution for Peritoneal Dialysis
NCT01242904Phase 2Completed
- Start
- Sep 2010
- Primary completion
- Feb 2015
- Modality
- Polymer-based Nanoparticles, Device-based Delivery, Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial of sodium potassium magnesium calcium and glucose injection and icodextrin in end stage renal disease (ESRD) (2 arms). Primary endpoint: Net Ultrafiltration Efficiency at 6 weeks. Started Sep 2010; status: completed.
02
Drugs
sodium potassium magnesium calcium and glucose injectionicodextrin
03
Conditions
end stage renal disease (ESRD)
Beyond the preview
Go deeper on NCT01242904.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01242904.